{"id":144586,"date":"2025-02-09T16:00:00","date_gmt":"2025-02-09T10:30:00","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=144586"},"modified":"2025-02-07T17:21:24","modified_gmt":"2025-02-07T11:51:24","slug":"ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/","title":{"rendered":"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3808661866\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-1231007308\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Share Price Movement&nbsp;<\/strong><\/h2><p>With a market capitalization of Rs. 10,216.83 Crores, the shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stocks\/AMIORG\">Ami Organics Limited<\/a><\/strong> were down by 1.26 percent in the day\u2019s trade touching a day\u2019s low of Rs. 2,476.50 per share lower than the previous closing price of Rs. 2,527.65 apiece. It has delivered a multibagger return of 127 percent which has outperformed the Nifty Index in the past year.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>CDMO Outlook and Revenue Guidance<\/strong><\/h2><p>The company is confident about strong growth in its CDMO business and expects it to reach Rs. 1,000 crores by FY28, up from Rs. 80 to 90 crores last year. The business has multiple projects in the final stages of development, with commercialization expected by FY26. Given the visibility for Q4FY25, the company has revised its FY25 growth guidance upward from 30 percent earlier to 35 percent.&nbsp;<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Capex Plans<\/strong><\/h2><p>Capital expenditure for FY25 stands at Rs. 118 crores, with significant investment in Ankleshwar and solar and electrolyte additive projects. They have secured long-term growth with business visibility until 2040 in its originator, generic, and first-to-file segments.&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2376758006\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Diversification to Growth Sectors<\/strong><\/h2><p>Baba Fine Chem is a key investment, the company has its focus on the semiconductor sector to grow and produce photoresist chemicals and other materials for Japan and Korea. The Electrolyte additives are also becoming a significant growth driver, with more than 12 additives developed for battery cell manufacturers.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Q3YF25 Financial Highlights&nbsp;<\/strong><\/h2><p>The financial results for the quarter ending December 2024, Ami Organics consolidated revenue from operations has increased by 65.66 percent year on year from Rs. 166 crore in Q3FY24 to Rs. 275 crore in Q3FY25 and increased by 11.33 percent quarter on quarter from Rs. 247 crore in Q2FY25.&nbsp;<\/p><p>The company&#8217;s consolidated net profit has increased by 150 percent year on year from Rs. 18 crores in Q3FY24 to Rs. 45 crores in Q3FY25. As compared to Q2FY25, the company\u2019s net profit has increased by 18.42 percent quarter on quarter from Rs. 45 crore.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Business Segments<\/strong><\/h2><p>The company earns its revenue from Custom Synthesis and manufacturing of specialty chemicals with applications in Pharmaceutical API and others as its sole segment.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Ace Investor Stake<\/strong><\/h2><p>As of December 2024, Ace Investor Ashish Kacholia holds around 1.84 percent and kept consistent from September 2024.<\/p><h2 class=\"wp-block-heading has-medium-font-size\"><strong>Company Overview<\/strong><\/h2><p>Ami Organics Limited was established in 2010. It is an R&amp;D-driven manufacturer of specialty chemicals, advanced pharmaceutical intermediates, and APIs. They focus on New Chemical Entities, agrochemicals, and fine chemicals, with products supplied to over 500 customers across 50 countries<\/p><div class=\"trade-content-10\" id=\"trade-1740170278\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p><strong><em>Written By Santhosh S<\/em><\/strong><\/p><\/blockquote><p class=\"has-medium-font-size\"><strong>Disclaimer<\/strong><\/p><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on <a href=\"http:\/\/tradebrains.in\/\">tradebrains.in<\/a> are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing<\/strong>.<\/p><div class=\"trade-after-content\" id=\"trade-1227611050\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.&nbsp; Share Price Movement&nbsp; With a market capitalization of Rs. 10,216.83 [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":119107,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[1119,15211,7519,7520,1200,6630,948,936,2597],"class_list":["post-144586","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-ami-organics","tag-ami-organics-latest-news","tag-ami-organics-ltd","tag-ami-organics-ltd-latest-news","tag-ami-organics-share-price","tag-ashish-kacholia-stock","tag-stock-market","tag-stock-market-news","tag-stocks-to-watch"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist\" \/>\n<meta property=\"og:description\" content=\"Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-09T10:30:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/\",\"url\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/\",\"name\":\"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg\",\"datePublished\":\"2025-02-09T10:30:00+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg\",\"width\":1280,\"height\":854,\"caption\":\"bse building\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist - Trade Brains Features","description":"Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/","og_locale":"en_US","og_type":"article","og_title":"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist","og_description":"Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2025-02-09T10:30:00+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/","url":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/","name":"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg","datePublished":"2025-02-09T10:30:00+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Ace Investor Ashish Kacholia stock, deals in the business of manufacturing specialty chemicals with varied end usage and is focused on the development and manufacturing of advanced pharmaceutical intermediates for generic and regulated APIs and New Chemical Entities raises FY25 guidance and CDMO business outlook.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/02\/MARKET0020.jpg","width":1280,"height":854,"caption":"bse building"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/ashish-kacholia-stock-with-strong-growth-guidance-of-35-for-fy25-to-add-to-your-watchlist\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Ashish Kacholia stock with strong growth guidance of 35% for FY25 to add to your watchlist"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=144586"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144586\/revisions"}],"predecessor-version":[{"id":144590,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/144586\/revisions\/144590"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/119107"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=144586"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=144586"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=144586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}